1. Munz, C., Lunemann, J. D., Getts, M. T. & Miller, S. D. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Rev. Immunol. 9, 246–258 (2009).

   Google Scholar 

2. de Martel, C. & Franceschi, S. Infections and cancer: established associations and new hypotheses. Crit. Rev. Oncol. Hematol. 70, 183–194 (2009).

   PubMed  Google Scholar 

3. Tal, M. C. et al. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc. Natl Acad. Sci. USA 106, 2770–2775 (2009).

   CAS  PubMed  PubMed Central  Google Scholar 

4. Pichlmair, A. & Reis e Sousa, C. Innate recognition of viruses. Immunity 27, 370–383 (2007).

   CAS  PubMed  Google Scholar 

5. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nature Immunol. 5, 987–995 (2004).

   CAS  Google Scholar 

6. Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nature Med. 12, 1301–1309 (2006). This paper implicated the role of IL-10 in the persistence of LCMV infection of mice and showed the therapeutic value of its neutralization in achieving viral control.

   CAS  PubMed  Google Scholar 

7. Brady, M. T., MacDonald, A. J., Rowan, A. G. & Mills, K. H. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur. J. Immunol. 33, 3448–3457 (2003).

   CAS  PubMed  Google Scholar 

8. Hyodo, N., Nakamura, I. & Imawari, M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin. Exp. Immunol. 135, 462–466 (2004).

   CAS  PubMed  PubMed Central  Google Scholar 

9. Brockman, M. A. et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114, 346–356 (2009).

   CAS  PubMed  PubMed Central  Google Scholar 

10. Smit, J. J., Rudd, B. D. & Lukacs, N. W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203, 1153–1159 (2006).

    CAS  Google Scholar 

11. Guidotti, L. G. et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825–829 (1999).

    CAS  PubMed  Google Scholar 

12. Rehermann, B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119, 1745–1754 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

13. Favre, D. et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5, e1000295 (2009). This paper showed that T H 17 cells are induced after SIV infection and that the balance of T H 17 and T Reg cells is a crucial determinant in the progression of disease in pigtailed macaques but not in African green monkeys, in which T H 17 cells were progressively depleted by the virus.

    PubMed  PubMed Central  Google Scholar 

14. Rowan, A. G. et al. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-β. J. Immunol. 181, 4485–4494 (2008). This is the first study to show that viral antigen-specific T H 17 cells are induced in HCV-infected individuals and that viral protein (NS4)-induced TGFβ can inhibit the activity of T H 17 cells.

    CAS  PubMed  Google Scholar 

15. Bermejo-Martin, J. F. et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit. Care 13, R201 (2009).

    PubMed  PubMed Central  Google Scholar 

16. Culley, F. J., Pennycook, A. M., Tregoning, J. S., Hussell, T. & Openshaw, P. J. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol. 80, 4521–4527 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

17. Ravetch, J. In vivo veritas: the surprising roles of Fc receptors in immunity. Nature Immunol. 11, 183–185 (2010).

    CAS  Google Scholar 

18. Buchmeier, M. J. & Oldstone, M. B. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection. J. Immunol. 120, 1297–1304 (1978). This is the first report in which immune complex deposits were measured using sensitive immunofluorescence and radioimmunoprecipitation in the tissue sites after a viral infection.

    CAS  PubMed  Google Scholar 

19. Nowoslawski, A., Krawczynski, K., Nazarewicz, T. & Slusarczyk, J. Immunopathological aspects of hepatitis type B. Am. J. Med. Sci. 270, 229–239 (1975).

    CAS  PubMed  Google Scholar 

20. Johnson, R. J. et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 328, 465–470 (1993).

    CAS  PubMed  Google Scholar 

21. Kimmel, P. L. et al. Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327, 702–706 (1992).

    CAS  PubMed  Google Scholar 

22. Dakhama, A. et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J. Allergy Clin. Immunol. 123, 138–145 (2009).

    CAS  PubMed  Google Scholar 

23. Couper, K. N., Blount, D. G. & Riley, E. M. IL-10: the master regulator of immunity to infection. J. Immunol. 180, 5771–5777 (2008).

    CAS  PubMed  Google Scholar 

24. Vieira, P. et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl Acad. Sci. USA 88, 1172–1176 (1991).

    CAS  PubMed  PubMed Central  Google Scholar 

25. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V. & Pestka, S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA 97, 1695–1700 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

26. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683–765 (2001).

    CAS  PubMed  Google Scholar 

27. Sarangi, P. P., Sehrawat, S., Suvas, S. & Rouse, B. T. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J. Immunol. 180, 6297–6306 (2008).

    CAS  PubMed  Google Scholar 

28. Mangia, A. et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 25, 103–109 (2004).

    CAS  PubMed  Google Scholar 

29. Naicker, D. D. et al. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J. Infect. Dis. 200, 448–452 (2009).

    CAS  PubMed  Google Scholar 

30. Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nature Med. 15, 277–284 (2009). This study showed that by making IL-10, effector CD8⁺ T cells limit the extent of pulmonary tissue damage.

    CAS  PubMed  Google Scholar 

31. Elrefaei, M. et al. HIV-specific IL-10-positive CD8⁺ T cells suppress cytolysis and IL-2 production by CD8⁺ T cells. J. Immunol. 178, 3265–3271 (2007).

    CAS  PubMed  Google Scholar 

32. Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319–323 (2007).

    CAS  PubMed  Google Scholar 

33. Li, M. O. & Flavell, R. A. Contextual regulation of inflammation: a duet by transforming growth factor-β and interleukin-10. Immunity 28, 468–476 (2008).

    PubMed  Google Scholar 

34. Li, M. O. & Flavell, R. A. TGF-β: a master of all T cell trades. Cell 134, 392–404 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

35. Aung, H., Wu, M., Johnson, J. L., Hirsch, C. S. & Toossi, Z. Bioactivation of latent transforming growth factor β1 by Mycobacterium tuberculosis in human mononuclear phagocytes. Scand. J. Immunol. 61, 558–565 (2005).

    CAS  PubMed  Google Scholar 

36. Omer, F. M., de Souza, J. B., Corran, P. H., Sultan, A. A. & Riley, E. M. Activation of transforming growth factor β by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule. J. Exp. Med. 198, 1817–1827 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

37. Schultz-Cherry, S. & Hinshaw, V. S. Influenza virus neuraminidase activates latent transforming growth factor β. J. Virol. 70, 8624–8629 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

38. Beckham, J. D., Tuttle, K. & Tyler, K. L. Reovirus activates transforming growth factor β and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection. J. Virol. 83, 5035–5045 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

39. Alatrakchi, N. et al. Hepatitis C virus (HCV)-specific CD8⁺ cells produce transforming growth factor β that can suppress HCV-specific T-cell responses. J. Virol. 81, 5882–5892 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

40. Tinoco, R., Alcalde, V., Yang, Y., Sauer, K. & Zuniga, E. I. Cell-intrinsic transforming growth factor-β signaling mediates virus-specific CD8⁺ T cell deletion and viral persistence in vivo. Immunity 31, 145–157 (2009). This report showed that TGFβ functions intrinsically to limit CD8⁺T cell responses to viral infection.

    CAS  PubMed  PubMed Central  Google Scholar 

41. O'Connor, W. Jr et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nature Immunol. 10, 603–609 (2009).

    CAS  Google Scholar 

42. Hou, W., Kang, H. S. & Kim, B. S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206, 313–328 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

43. Rabinovich, G. A. & Toscano, M. A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nature Rev. Immunol. 9, 338–352 (2009).

    CAS  Google Scholar 

44. Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nature Immunol. 6, 1245–1252 (2005).

    CAS  Google Scholar 

45. Sehrawat, S., Suryawanshi, A., Hirashima, M. & Rouse, B. T. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182, 3191–3201 (2009). This paper showed that galectin 9 could promote FOXP3⁺ T Reg cell responses and that ligation of TIM3 with galectin 9 induces apoptosis of effector T cells but not T Reg cells.

    CAS  PubMed  Google Scholar 

46. Sehrawat, S., Reddy, P. B. J., Rajasagi, N., Suryawanshi, A., Hirashima, M. & Rouse, B. T. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8⁺ T cell response. PLoS Pathog. 6, e1000882 (2010).

    PubMed  PubMed Central  Google Scholar 

47. Chagan-Yasutan, H. et al. Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J. Exp. Med. 218, 285–92 (2009).

    CAS  PubMed  Google Scholar 

48. Mengshol, J. A. et al. A crucial role for kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 5, e9504 (2010).

    PubMed  PubMed Central  Google Scholar 

49. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455–458 (2000).

    CAS  PubMed  Google Scholar 

50. Belkaid, Y. & Tarbell, K. Regulatory T cells in the control of host-microorganism interactions. Annu. Rev. Immunol. 27, 551–589 (2009).

    CAS  PubMed  Google Scholar 

51. Suvas, S., Azkur, A. K., Kim, B. S., Kumaraguru, U. & Rouse, B. T. CD4⁺CD25⁺ regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172, 4123–4132 (2004).

    CAS  PubMed  Google Scholar 

52. Ruckwardt, T. J., Bonaparte, K. L., Nason, M. C. & Graham, B. S. Regulatory T cells promote early influx of CD8⁺ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J. Virol. 83, 3019–3028 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

53. Lanteri, M. C. et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 119, 3266–3277 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

54. Sehrawat, S., Suvas, S., Sarangi, P. P., Suryawanshi, A. & Rouse, B. T. In vitro-generated antigen-specific CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J. Virol. 82, 6838–6851 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

55. Sehrawat, S. & Rouse, B. T. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3⁺ regulators. J. Immunol. 180, 7636–7647 (2008).

    CAS  PubMed  Google Scholar 

56. Rouse, B. T., Sarangi, P. P. & Suvas, S. Regulatory T cells in virus infections. Immunol. Rev. 212, 272–286 (2006).

    CAS  PubMed  Google Scholar 

57. MacDonald, A. J. et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185, 720–727 (2002). This report showed that induction of T regulatory 1 cells in patients infected with HCV negatively correlated with the extent of liver damage.

    CAS  PubMed  Google Scholar 

58. Liew, F. Y., Xu, D., Brint, E. K. & O'Neill, L. A. Negative regulation of Toll-like receptor-mediated immune responses. Nature Rev. Immunol. 5, 446–458 (2005).

    CAS  Google Scholar 

59. Virgin, H. W., Wherry, E. J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30–50 (2009).

    CAS  PubMed  Google Scholar 

60. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006). This seminal paper showed that the functional T cell exhaustion caused by a chronic viral infection could be reversed using antibody specific for the inhibitory molecule PD1.

    CAS  PubMed  Google Scholar 

61. Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350–354 (2006). This report showed that antigen-specific CD8⁺ T cells isolated from patients with HIV expressed higher levels of the inhibitory molecule PD1 and that the exhaustion could be reversed, at least ex vivo , by using blocking antibody.

    CAS  PubMed  Google Scholar 

62. Radziewicz, H. et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81, 2545–2553 (2007).

    CAS  PubMed  Google Scholar 

63. Maier, H., Isogawa, M., Freeman, G. J. & Chisari, F. V. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8⁺ T lymphocytes in the liver. J. Immunol. 178, 2714–2720 (2007).

    CAS  PubMed  Google Scholar 

64. Said, E. A. et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4⁺ T cell activation during HIV infection. Nature Med. 16, 452–459 (2010).

    CAS  PubMed  Google Scholar 

65. Yao, Z. Q., King, E., Prayther, D., Yin, D. & Moorman, J. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol. 20, 276–287 (2007).

    CAS  PubMed  Google Scholar 

66. Boasso, A. et al. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin. Immunol. 129, 132–144 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

67. Brooks, D. G. et al. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc. Natl Acad. Sci. USA 105, 20428–20433 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

68. Blackburn, S. D. et al. Coregulation of CD8⁺ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunol. 10, 29–37 (2009).

    CAS  Google Scholar 

69. Brooks, D. G., Lee, A. M., Elsaesser, H., McGavern, D. B. & Oldstone, M. B. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J. Exp. Med. 205, 533–541 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

70. Ha, S. J. et al. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J. Exp. Med. 205, 543–555 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

71. Racaniello, V. R. One hundred years of poliovirus pathogenesis. Virology 344, 9–16 (2006).

    CAS  PubMed  Google Scholar 

72. Whitley, R. J. Herpes Simplex Viruses (eds Knipe, D. M & Howley, P. M.) (Lippincott Williams & Wilkins, New York, 2001).

    Google Scholar 

73. Tabeta, K. et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nature Immunol. 7, 156–164 (2006).

    CAS  Google Scholar 

74. Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007).

    CAS  PubMed  Google Scholar 

75. McIntosh, E. D. Paediatric infections: prevention of transmission and disease — implications for adults. Vaccine 23, 2087–2089 (2005).

    PubMed  Google Scholar 

76. Rothberg, M. B., Haessler, S. D. & Brown, R. B. Complications of viral influenza. Am. J. Med. 121, 258–264 (2008).

    PubMed  PubMed Central  Google Scholar 

77. Tregoning, J. S. & Schwarze, J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol Rev. 23, 74–98 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

78. Collins, P. L. & Graham, B. S. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82, 2040–2055 (2008).

    CAS  PubMed  Google Scholar 

79. Spann, K. M., Tran, K. C., Chi, B., Rabin, R. L. & Collins, P. L. Suppression of the induction of α, β, and λ interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78, 4363–4369 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

80. Smit, J. J. et al. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS ONE 3, e1720 (2008).

    PubMed  PubMed Central  Google Scholar 

81. Culley, F. J., Pollott, J. & Openshaw, P. J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196, 1381–1386 (2002). The influence of age at first exposure to a viral infection on the susceptibility of the same infection later in the life was shown in a mouse model of RSV infection.

    CAS  PubMed  PubMed Central  Google Scholar 

82. Whitley, R. J. A 70-year-old woman with shingles: review of herpes zoster. JAMA 302, 73–80 (2009).

    CAS  PubMed  Google Scholar 

83. Rouse, B. T. & Kaistha, S. D. A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Clin. Infect. Dis. 42, 810–817 (2006).

    PubMed  Google Scholar 

84. Nikolich-Zugich, J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nature Rev. Immunol. 8, 512–522 (2008).

    CAS  Google Scholar 

85. Maue, A. C. et al. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 30, 301–305 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

86. Snyder, C. M. et al. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29, 650–659 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

87. Schakel, K. Dendritic cells — why can they help and hurt us. Exp. Dermatol. 18, 264–273 (2009).

    PubMed  Google Scholar 

88. Haaland, R. E. et al. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 5, e1000274 (2009).

    PubMed  PubMed Central  Google Scholar 

89. McDermott, A. B. et al. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J. Virol. 78, 3140–3144 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

90. Oh, S., McCaffery, J. M. & Eichelberger, M. C. Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. J. Virol. 74, 5460–5469 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

91. Legge, K. L. & Braciale, T. J. Lymph node dendritic cells control CD8⁺ T cell responses through regulated FasL expression. Immunity 23, 649–659 (2005).

    CAS  PubMed  Google Scholar 

92. Asabe, S. et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J. Virol. 83, 9652–9662 (2009). This study investigated the influence of dose of infecting HBV on the pathogenesis of liver disease and clearly showed that very high or very low doses of infection led to severe liver damage.

    CAS  PubMed  PubMed Central  Google Scholar 

93. King, N. J. et al. Immunopathology of flavivirus infections. Immunol. Cell Biol. 85, 33–42 (2007).

    CAS  PubMed  Google Scholar 

94. Wang, T. et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Med. 10, 1366–1373 (2004).

    CAS  PubMed  Google Scholar 

95. Koelle, D. M. & Corey, L. Herpes simplex: insights on pathogenesis and possible vaccines. Annu. Rev. Med. 59, 381–395 (2008).

    CAS  PubMed  Google Scholar 

96. Weiner, L. P. Pathogenesis of demyelination induced by a mouse hepatitis. Arch. Neurol. 28, 298–303 (1973).

    CAS  PubMed  Google Scholar 

97. Fazakerley, J. K. & Walker, R. Virus demyelination. J. Neurovirol. 9, 148–164 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

98. Cole, G. A., Nathanson, N. & Prendergast, R. A. Requirement for θ-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238, 335–337 (1972).

    CAS  PubMed  Google Scholar 

99. Halstead, S. B. Dengue. Lancet 370, 1644–1652 (2007).

    PubMed  Google Scholar 

100. Mathew, A. & Rothman, A. L. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225, 300–313 (2008).

     CAS  PubMed  Google Scholar 

101. Hadinoto, V. et al. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111, 1420–1427 (2008).

     CAS  PubMed  PubMed Central  Google Scholar 

102. Clute, S. C. et al. Cross-reactive influenza virus-specific CD8⁺ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J. Clin. Invest. 115, 3602–3612 (2005). This study showed that major contributors to infectious mononucleosis are cross-reactive T cells specific for a previously encountered virus.

     CAS  PubMed  PubMed Central  Google Scholar 

103. Kim, S. K. et al. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201, 523–533 (2005).

     CAS  PubMed  PubMed Central  Google Scholar 

104. Welsh, R. M. & Fujinami, R. S. Pathogenic epitopes, heterologous immunity and vaccine design. Nature Rev. Microbiol. 5, 555–563 (2007).

     CAS  Google Scholar 

105. Segal, S. & Hill, A. V. Genetic susceptibility to infectious disease. Trends Microbiol. 11, 445–448 (2003).

     CAS  PubMed  Google Scholar 

106. Goulder, P. J. & Watkins, D. I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nature Rev. Immunol. 8, 619–630 (2008).

     CAS  Google Scholar 

107. Brass, A. L. et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921–926 (2008).

     CAS  PubMed  Google Scholar 

108. Good, R. A. & Hansen, M. A. Primary immunodeficiency diseases. Adv. Exp. Med. Biol. 73, 155–178 (1976).

     PubMed  Google Scholar 

109. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377 (1996).

     CAS  PubMed  Google Scholar 

110. Hill, A. V. Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet. 40, 469–486 (2006).

     CAS  PubMed  Google Scholar 

111. Casrouge, A. et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308–312 (2006).

     CAS  PubMed  Google Scholar 

112. Zhang, S. Y. et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense. Immunol. Rev. 226, 29–40 (2008).

     CAS  PubMed  Google Scholar 

113. Kaur, G. & Mehra, N. Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. Tissue Antigens 73, 289–301 (2009).

     CAS  PubMed  PubMed Central  Google Scholar 

114. Hubert, J. B. et al. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. AIDS 14, 123–131 (2000). This study showed that some patients with HIV can control the virus for a long time without the need for antiretroviral therapy.

     CAS  PubMed  Google Scholar 

115. Seifarth, W. et al. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J. Virol. 79, 341–352 (2005).

     CAS  PubMed  PubMed Central  Google Scholar 

116. Lower, R., Lower, J. & Kurth, R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl Acad. Sci. USA 93, 5177–5184 (1996).

     CAS  PubMed  PubMed Central  Google Scholar 

117. Wilkins, C. & Gale, M. Jr. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22, 41–47 (2001).

     Google Scholar 

118. York, I. A. et al. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8⁺ T lymphocytes. Cell 77, 525–535 (1994).

     CAS  PubMed  Google Scholar 

119. Ahn, K. et al. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl Acad. Sci. USA 93, 10990–10995 (1996).

     CAS  PubMed  PubMed Central  Google Scholar 

120. Gilbert, M. J., Riddell, S. R., Plachter, B. & Greenberg, P. D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383, 720–722 (1996).

     CAS  PubMed  Google Scholar 

121. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. & Masucci, M. G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl Acad. Sci. USA 94, 12616–12621 (1997).

     CAS  PubMed  PubMed Central  Google Scholar 

122. Koppelman, B., Neefjes, J. J., de Vries, J. E. & de Waal Malefyt, R. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7, 861–871 (1997).

     CAS  PubMed  Google Scholar 

123. Greenberg, M. E. et al. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16, 6964–6976 (1997).

     CAS  PubMed  PubMed Central  Google Scholar 

124. Holmes, E. C. Evolutionary history and phylogeography of human viruses. Annu. Rev. Microbiol. 62, 307–328 (2008).

     CAS  PubMed  Google Scholar 

125. Devergne, O., Birkenbach, M. & Kieff, E. Epstein–Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl Acad. Sci. USA 94, 12041–12046 (1997).

     CAS  PubMed  PubMed Central  Google Scholar 

126. Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758–761 (1993).

     CAS  PubMed  Google Scholar 

127. Periwal, S. B. & Cebra, J. J. Respiratory mucosal immunization with reovirus serotype 1/L stimulates virus-specific humoral and cellular immune responses, including double-positive (CD4⁺/CD8⁺) T cells. J. Virol. 73, 7633–7640 (1999).

     CAS  PubMed  Google Scholar 

128. Fulton, J. R., Smith, J., Cunningham, C. & Cuff, C. F. Influence of the route of infection on development of T-cell receptor β-chain repertoires of reovirus-specific cytotoxic T lymphocytes. J. Virol. 78, 1582–1590 (2004).

     CAS  PubMed  PubMed Central  Google Scholar 

129. Le Goffic, R. et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, e53 (2006).

     PubMed  Google Scholar 

130. Bochud, P. Y., Magaret, A. S., Koelle, D. M., Aderem, A. & Wald, A. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus type 2 infection. J. Infect. Dis. 196, 505–509 (2007).

     CAS  PubMed  Google Scholar 

131. Almarri, A. & Batchelor, J. R. HLA and hepatitis B infection. Lancet 344, 1194–1195 (1994).

     CAS  PubMed  Google Scholar 

132. Gao, X. et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nature Med. 11, 1290–1292 (2005).

     CAS  PubMed  Google Scholar 

133. Fellay, J. et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944–947 (2007).

     CAS  PubMed  PubMed Central  Google Scholar 

134. Fanning, L. J. et al. HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 33, 224–230 (2001).

     CAS  PubMed  Google Scholar 

135. Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798–801 (2009).

     CAS  PubMed  PubMed Central  Google Scholar 

136. Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009).

     CAS  PubMed  Google Scholar 

137. Knapp, S. et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 4, 411–419 (2003).

     CAS  PubMed  Google Scholar 

138. Monto, A. S. Epidemiology of influenza. Vaccine 26, D45–D48 (2008).

     PubMed  Google Scholar 

139. Peebles, R. S. Jr & Graham, B. S. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc. Am. Thorac Soc. 2, 110–115 (2005).

     CAS  PubMed  PubMed Central  Google Scholar 

140. Lemke, G. & Rothlin, C. V. Immunobiology of the TAM receptors. Nature Rev. Immunol. 8, 327–336 (2008).

     CAS  Google Scholar 

Download references